iris tech
iris technologies international gmbh
RECIPE products
- ClinRep© | Clinical Diagnostics |
HPLC
Complete Kits - ClinRep© | Therapeutic Drug Monitoring | HPLC
Complete Kits
- ClinTox© | Human Bio-
monitoring | HPLC
Complete Kits - ClinMass© | LC-MS/MS
- ClinCal© Matrix Calibrators
- ClinChek© Matrix Controls
- ClinTest© Solutions
- RECIPE News
BIOTICA products
MINERVA products
Mynox® Gold:
Mycoplasma Elimination, 2 in 1 - Double Strength
Cat.-No. 10-0201 2 Applications
Cat.-No. 10-0501 5 Applications
Cat.-No. 10-1001 10 Applications
![]() |
Description Mynox®Gold represents the further development of the classical Mynox®, which was known for a very high elimination efficiency and low cytotoxicity. Mynox®Gold is a combination of a standard antibiotic and a biological reagent. One application comprises of 4 vials, a starter treatment and three main treatments. The starter treatment kills most of the mycoplasma particles without harming the cells. The main treatment kills all remaining mycoplasma leading to a permanent eradication with efficiency rates up to 100 %. One application can be used to cure one cell culture permanently from mycoplasma burden. |
![]() |
No cytotoxicity Highly effective Universal for cell lines Universal for mycoplasma Low resistance risk Format Interoperable |
Mynox®Gold is intended for research use only. Not recommended for clinical treatment.
Store the original container at temperatures of +2 to + 8 °C.

Cytotoxicity of Mynox®Gold on contami nated cells. Adherent cell lines were treated with Mynox®Gold according to the protocol 4 days of incubation. The cultures were in activated and stained as described by Flick & Gifford. Untreated cultures had been used as reference (100 %).

